Entry |
|
Symbol |
AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA
|
Name |
(RefSeq) AKT serine/threonine kinase 2
|
KO |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04072 | Phospholipase D signaling pathway |
hsa04213 | Longevity regulating pathway - multiple species |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04550 | Signaling pathways regulating pluripotency of stem cells |
hsa04613 | Neutrophil extracellular trap formation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04810 | Regulation of actin cytoskeleton |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04919 | Thyroid hormone signaling pathway |
hsa04920 | Adipocytokine signaling pathway |
hsa04923 | Regulation of lipolysis in adipocytes |
hsa04932 | Non-alcoholic fatty liver disease |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa04973 | Carbohydrate digestion and absorption |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05168 | Herpes simplex virus 1 infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
hsa05208 | Chemical carcinogenesis - reactive oxygen species |
hsa05230 | Central carbon metabolism in cancer |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
hsa05418 | Fluid shear stress and atherosclerosis |
|
Network |
|
Element |
N00030 | EGF-EGFR-RAS-PI3K signaling pathway |
N00031 | Duplication or mutation-activated FLT3 to RAS-PI3K signaling pathway |
N00032 | Mutation-activated KRAS/NRAS to PI3K signaling pathway |
N00033 | EGF-EGFR-PI3K signaling pathway |
N00034 | ERBB2-overexpression to PI3K signaling pathway |
N00035 | Amplified EGFR to PI3K signaling pathway |
N00036 | Mutation-activated EGFR to PI3K signaling pathway |
N00037 | FGF-FGFR-PI3K signaling pathway |
N00038 | Amplified FGFR to PI3K signaling pathway |
N00039 | PDGF-PDGFR-PI3K signaling pathway |
N00040 | Amplified PDGFR to PI3K signaling pathway |
N00042 | EGFR-overexpression to PI3K signaling pathway |
N00043 | HGF-MET-PI3K signaling pathway |
N00044 | Mutation-activated MET to PI3K signaling pathway |
N00045 | KITLG-KIT-PI3K signaling pathway |
N00046 | Mutation-activated KIT to PI3K signaling pathway |
N00047 | EML4-ALK fusion kinase to PI3K signaling pathway |
N00048 | BCR-ABL fusion kinase to PI3K signaling pathway |
N00049 | Mutation-activated PI3K to PI3K signaling pathway |
N00050 | Amplified PI3K to PI3K signaling pathway |
N00051 | Deleted PTEN to PI3K signaling pathway |
N00052 | Mutation-inactivated PTEN to PI3K signaling pathway |
N00082 | Loss of NKX3-1 to PI3K signaling pathway |
N00154 | CXCR-GNB/G-PI3K-AKT signaling pathway |
N00182 | IGF-IGFR-PI3K-NFKB signaling pathway |
N00218 | FLT3LG-FLT3-RAS-PI3K signaling pathway |
N00220 | PTEN-PIP3-AKT signaling pathway |
N00231 | TGFA-EGFR-PI3K signaling pathway |
N00232 | TGFA-overexpression to PI3K signaling pathway |
N00234 | IGF2-IGF1R-PI3K signaling pathway |
N00236 | IGF2-overexpression to PI3K signaling pathway |
N00238 | IGF1R-overexpression to PI3K signaling pathway |
N00247 | HGF-overexpression to PI3K signaling pathway |
N00249 | MET-overexpression to PI3K signaling pathway |
N00253 | Amplified ERBB2 to PI3K signaling pathway |
N00260 | Amplified MET to PI3K signaling pathway |
N00281 | EGF-overexpression to PI3K signaling pathway |
N00282 | EREG-EGFR-PI3K signaling pathway |
N00283 | EREG-overexpression to PI3K signaling pathway |
N00284 | AREG-EGFR-PI3K signaling pathway |
N00285 | AREG-overexpression to PI3K signaling pathway |
N00342 | MAGI-PTEN signaling pathway |
N00355 | PP2A-AKT signaling pathway |
N00390 | EGF-EGFR-PI3K-NFKB signaling pathway |
N00399 | CCR2-GNB/G-PI3K-NFKB signaling pathway |
N00430 | CXCR4-GNAI-PI3K-BAD signaling pathway |
N00514 | Mutation-activated EGFR to PI3K signaling pathway |
N00582 | IGF-IGF1R-PI3K signaling pathway |
N00683 | CD80/CD86-CD28-PI3K signaling pathway |
N00963 | RELN-VLDLR-PI3K signaling pathway |
N00964 | DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway |
N01063 | Mutation-activated MET to PI3K signaling pathway |
N01065 | Mutation-activated RET to PI3K signaling pathway |
N01163 | NRG-ERBB4-PI3K signaling pathway |
N01338 | ACH-CHRN-PI3K signaling pathway |
N01339 | NNK/NNN to PI3K signaling pathway |
N01347 | EP/NE-ADRB-PI3K signaling pathway |
N01348 | Nicotine/NNK to PI3K signaling pathway |
N01349 | ACH-CHRN-PI3K signaling pathway |
N01350 | NNK/NNN to PI3K signaling pathway |
N01355 | Arsenic to PI3K signaling pathway |
N01356 | Membrane-initiated progesterone signaling pathway |
N01357 | P4/MPA to membrane-initiated progesterone signaling pathway |
N01358 | P4-PR-PI3K signaling pathway |
N01359 | P4/MPA to PR-PI3K signaling pathway |
N01409 | Metals to PI3K signaling pathway |
N01579 | CD80/CD86-CTLA4-PP2A signaling pathway |
N01656 | GF-RTK-PI3K signaling pathway |
N01657 | GPCR-PI3K signaling pathway |
N01658 | GF-RTK-RAS-PI3K signaling pathway |
N01695 | BCR-BCAP/CD19-PI3K signaling pathway |
N01696 | ICOSLG/ICOS-PI3K signaling pathway |
N01833 | DRAXIN-MAP1B axon guidance signaling |
N01858 | EFNB1-MAPT axon guidance signaling |
N01875 | NRG-ERBB2/ERBB3 pathway (P13K signaling) |
|
Disease |
H00409 | Type 2 diabetes mellitus |
H00420 | Familial partial lipodystrophy |
H01909 | Hypoinsulinemic hypoglycemia with hemihypertrophy |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04014 Ras signaling pathway
208 (AKT2)
04015 Rap1 signaling pathway
208 (AKT2)
04630 JAK-STAT signaling pathway
208 (AKT2)
04668 TNF signaling pathway
208 (AKT2)
04066 HIF-1 signaling pathway
208 (AKT2)
04068 FoxO signaling pathway
208 (AKT2)
04072 Phospholipase D signaling pathway
208 (AKT2)
04071 Sphingolipid signaling pathway
208 (AKT2)
04024 cAMP signaling pathway
208 (AKT2)
04022 cGMP-PKG signaling pathway
208 (AKT2)
04151 PI3K-Akt signaling pathway
208 (AKT2)
04152 AMPK signaling pathway
208 (AKT2)
04150 mTOR signaling pathway
208 (AKT2)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
208 (AKT2)
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
208 (AKT2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
208 (AKT2)
04613 Neutrophil extracellular trap formation
208 (AKT2)
04620 Toll-like receptor signaling pathway
208 (AKT2)
04660 T cell receptor signaling pathway
208 (AKT2)
04662 B cell receptor signaling pathway
208 (AKT2)
04664 Fc epsilon RI signaling pathway
208 (AKT2)
04666 Fc gamma R-mediated phagocytosis
208 (AKT2)
04062 Chemokine signaling pathway
208 (AKT2)
09152 Endocrine system
04922 Glucagon signaling pathway
208 (AKT2)
04923 Regulation of lipolysis in adipocytes
208 (AKT2)
04929 GnRH secretion
208 (AKT2)
04915 Estrogen signaling pathway
208 (AKT2)
04917 Prolactin signaling pathway
208 (AKT2)
04926 Relaxin signaling pathway
208 (AKT2)
04935 Growth hormone synthesis, secretion and action
208 (AKT2)
04919 Thyroid hormone signaling pathway
208 (AKT2)
09154 Digestive system
04973 Carbohydrate digestion and absorption
208 (AKT2)
09156 Nervous system
04725 Cholinergic synapse
208 (AKT2)
04728 Dopaminergic synapse
208 (AKT2)
04722 Neurotrophin signaling pathway
208 (AKT2)
09158 Development and regeneration
04380 Osteoclast differentiation
208 (AKT2)
09149 Aging
04211 Longevity regulating pathway
208 (AKT2)
04213 Longevity regulating pathway - multiple species
208 (AKT2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
208 (AKT2)
05205 Proteoglycans in cancer
208 (AKT2)
05207 Chemical carcinogenesis - receptor activation
208 (AKT2)
05208 Chemical carcinogenesis - reactive oxygen species
208 (AKT2)
05230 Central carbon metabolism in cancer
208 (AKT2)
05231 Choline metabolism in cancer
208 (AKT2)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
208 (AKT2)
09162 Cancer: specific types
05210 Colorectal cancer
208 (AKT2)
05212 Pancreatic cancer
208 (AKT2)
05225 Hepatocellular carcinoma
208 (AKT2)
05226 Gastric cancer
208 (AKT2)
05214 Glioma
208 (AKT2)
05221 Acute myeloid leukemia
208 (AKT2)
05220 Chronic myeloid leukemia
208 (AKT2)
05218 Melanoma
208 (AKT2)
05211 Renal cell carcinoma
208 (AKT2)
05215 Prostate cancer
208 (AKT2)
05213 Endometrial cancer
208 (AKT2)
05224 Breast cancer
208 (AKT2)
05222 Small cell lung cancer
208 (AKT2)
05223 Non-small cell lung cancer
208 (AKT2)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
208 (AKT2)
05170 Human immunodeficiency virus 1 infection
208 (AKT2)
05161 Hepatitis B
208 (AKT2)
05160 Hepatitis C
208 (AKT2)
05164 Influenza A
208 (AKT2)
05162 Measles
208 (AKT2)
05163 Human cytomegalovirus infection
208 (AKT2)
05167 Kaposi sarcoma-associated herpesvirus infection
208 (AKT2)
05169 Epstein-Barr virus infection
208 (AKT2)
05165 Human papillomavirus infection
208 (AKT2)
09171 Infectious disease: bacterial
05131 Shigellosis
208 (AKT2)
05135 Yersinia infection
208 (AKT2)
05152 Tuberculosis
208 (AKT2)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
208 (AKT2)
05142 Chagas disease
208 (AKT2)
09164 Neurodegenerative disease
05010 Alzheimer disease
208 (AKT2)
05017 Spinocerebellar ataxia
208 (AKT2)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
208 (AKT2)
05418 Fluid shear stress and atherosclerosis
208 (AKT2)
05415 Diabetic cardiomyopathy
208 (AKT2)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
208 (AKT2)
04932 Non-alcoholic fatty liver disease
208 (AKT2)
04931 Insulin resistance
208 (AKT2)
04933 AGE-RAGE signaling pathway in diabetic complications
208 (AKT2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
208 (AKT2)
01524 Platinum drug resistance
208 (AKT2)
01522 Endocrine resistance
208 (AKT2)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:hsa01001]
208 (AKT2)
Enzymes [BR:hsa01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.1 non-specific serine/threonine protein kinase
208 (AKT2)
Protein kinases [BR:hsa01001]
Serine/threonine kinases: AGC group
AKT/PKB family
208 (AKT2)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
19:complement(40230317..40285345)
|
AA seq |
481 aa
MNEVSVIKEGWLHKRGEYIKTWRPRYFLLKSDGSFIGYKERPEAPDQTLPPLNNFSVAEC
QLMKTERPRPNTFVIRCLQWTTVIERTFHVDSPDEREEWMRAIQMVANSLKQRAPGEDPM
DYKCGSPSDSSTTEEMEVAVSKARAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAM
KILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH
LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG
ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE
LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK
KLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHFPQFSYSASIR
E |
NT seq |
1446 nt +upstreamnt +downstreamnt
atgaatgaggtgtctgtcatcaaagaaggctggctccacaagcgtggtgaatacatcaag
acctggaggccacggtacttcctgctgaagagcgacggctccttcattgggtacaaggag
aggcccgaggcccctgatcagactctaccccccttaaacaacttctccgtagcagaatgc
cagctgatgaagaccgagaggccgcgacccaacacctttgtcatacgctgcctgcagtgg
accacagtcatcgagaggaccttccacgtggattctccagacgagagggaggagtggatg
cgggccatccagatggtcgccaacagcctcaagcagcgggccccaggcgaggaccccatg
gactacaagtgtggctcccccagtgactcctccacgactgaggagatggaagtggcggtc
agcaaggcacgggctaaagtgaccatgaatgacttcgactatctcaaactccttggcaag
ggaacctttggcaaagtcatcctggtgcgggagaaggccactggccgctactacgccatg
aagatcctgcggaaggaagtcatcattgccaaggatgaagtcgctcacacagtcaccgag
agccgggtcctccagaacaccaggcacccgttcctcactgcgctgaagtatgccttccag
acccacgaccgcctgtgctttgtgatggagtatgccaacgggggtgagctgttcttccac
ctgtcccgggagcgtgtcttcacagaggagcgggcccggttttatggtgcagagattgtc
tcggctcttgagtacttgcactcgcgggacgtggtataccgcgacatcaagctggaaaac
ctcatgctggacaaagatggccacatcaagatcactgactttggcctctgcaaagagggc
atcagtgacggggccaccatgaaaaccttctgtgggaccccggagtacctggcgcctgag
gtgctggaggacaatgactatggccgggccgtggactggtgggggctgggtgtggtcatg
tacgagatgatgtgcggccgcctgcccttctacaaccaggaccacgagcgcctcttcgag
ctcatcctcatggaagagatccgcttcccgcgcacgctcagccccgaggccaagtccctg
cttgctgggctgcttaagaaggaccccaagcagaggcttggtggggggcccagcgatgcc
aaggaggtcatggagcacaggttcttcctcagcatcaactggcaggacgtggtccagaag
aagctcctgccacccttcaaacctcaggtcacgtccgaggtcgacacaaggtacttcgat
gatgaatttaccgcccagtccatcacaatcacaccccctgaccgctatgacagcctgggc
ttactggagctggaccagcggacccacttcccccagttctcctactcggccagcatccgc
gagtga |